We performed a meta-analysis to assess the association of diabetes mellitus (DM) with the presence of thoracic aortic dissection (TAD) and/or thoracic aortic aneurysm (TAA). MEDLINE and EMBASE were searched through December 2015 using PubMed and OVID. For each study, data regarding DM prevalence in both the TAD/TAA and control groups were used to generate unadjusted odds ratios (ORs) for DM and 95% confidence intervals (CIs). Alternatively, an unadjusted and/or adjusted OR was directly abstracted from each individual study. Eleven eligible studies enrolling a total of 47 827 participants were included. A primary pooled analysis of all the 11 studies demonstrated that TAD/TAA was associated with significantly lower DM prevalence than controls (OR, 0.43; 95% CI, 0.31-0.59; P < .00001). Separate pooled analyses of 6 TAD case studies and 4 TAA case studies demonstrated TAD (OR, 0.34; 95% CI, 0.19-0.61; P = .0003) and TAA (OR, 0.65; 95% CI, 0.45-0.94; P = .02) were associated with significantly lower DM prevalence than controls. In conclusion, DM may be negatively associated with the presence of TAD/TAA.
CornuzJSidoti PintoCTevaearaiHEggerM. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health. 2004;14(4):343–349.
2.
LiXZhaoGZhangJDuanZXinS. Prevalence and trends of the abdominal aortic aneurysms epidemic in general population—a meta-analysis. PLoS One. 2013;8(12):e81260.
3.
TakagiHUmemotoT. A contemporary meta-analysis of the association of diabetes with abdominal aortic aneurysm. Int Angiol. 2015;34(4):375–382.
4.
TakagiHUmemotoT. Diabetes and abdominal aortic aneurysm growth. Angiology. 2016;67(6):513–525.
5.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
6.
EggerMDavey SmithGSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
7.
AchneckHModiBShawC. Ascending thoracic aneurysms are associated with decreased systemic atherosclerosis. Chest. 2005;128(3):1580–1586.
8.
FanariZHammamiSHammamiMBHammamiSEze-NliamCWeintraubWS. Using the descending aortic wall thickness measured in transesophageal echocardiography as a risk marker for aortic dissection. Eur J Cardiovasc Med. 2015;3(1):448–451.
9.
HeXLiuXLiuW. Association between diabetes and risk of aortic dissection: a case–control study in a Chinese population. PLoS One. 2015;10(11):e0142697.
10.
LiuOLiJRGongMXuMDuJZhangHJ. Genetic analysis of six SNPs in candidate genes associated with high cross-race risk of development of thoracic aortic aneurysms and dissections in Chinese Han population. Acta Pharmacol Sin. 2010;31(10):1376–1380.
11.
PrakashSKPedrozaCKhalilYAMilewiczDM. Diabetes and reduced risk for thoracic aortic aneurysms and dissections: a nationwide case–control study. J Am Heart Assoc. 2012;1(2).
12.
TheivacumarNSStephensonMAMistryHValentiD. Diabetics are less likely to develop thoracic aortic dissection: a 10-year single-center analysis. Ann Vasc Surg. 2014;28(2):427–432.
13.
ChaerRAVasoncelosRMaroneLK. Synchronous and metachronous thoracic aneurysms in patients with abdominal aortic aneurysms. J Vasc Surg. 2012;56(5):1261–1265.
14.
HungAZafarMMukherjeeSTranquilliMScouttLMElefteriadesJA. Carotid intima-media thickness provides evidence that ascending aortic aneurysm protects against systemic atherosclerosis. Cardiology. 2012;123(2):71–77.
15.
ItoSAkutsuKTamoriY. Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol. 2008;101(5):696–699.
16.
TheivacumarNSStephensonMAMistryHValentiD. Diabetes mellitus and aortic aneurysm rupture: a favorable association?Vasc Endovasc Surg. 2014;48(1):45–50.
17.
LeitmanIMSuzukiKWengrofskyAJ. Early recognition of acute thoracic aortic dissection and aneurysm. World J Emerg Surg. 2013;8(1):47.
18.
TsaiCLLinCLWuYYShiehDCSungFCKaoCH. Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study. Diabetes Metab Res Rev. 2015;31(2):190–197.
19.
De RangoPFarchioniLFiorucciBLentiM. Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014;47(3):243–261.
20.
SweetingMJThompsonSGBrownLCPowellJT; RESCAN Collaborators. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg. 2012;99(5):655–665.
BaumgartnerIHirschATAbolaMT; REACH Registry Investigators. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg. 2008;48(4):808–814.
23.
GolledgeJKaranMMoranCS. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte–matrix interactions. Eur Heart J. 2008;29(5):665–672.
24.
SakataNMengJTakebayashiS. Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb. 2000;7(3):169–176.
25.
DuaMMMiyamaNAzumaJ. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery. 2010;148(2):429–435.
26.
MadiHARichesKWarburtonPO’ReganDJTurnerNAPorterKE. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and type 2 diabetic patients. Am J Physiol Cell Physiol. 2009;297(5):c1307–c1317.
27.
AronsonD. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21(1):3–12.
28.
GaoLKangLChenQChenCXuBJiangS. Advanced glycation end products inhibit production and activity of matrix metalloproteinase-2 in human umbilical vein endothelial cells. J Int Med Res. 2007;35(5):709–715.
29.
Portik-DobosVAnstadtMPHutchinsonJBannanMErgulA. Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes. 2002;51(10):3063–3068.
30.
ClouseWDHallettJWJrSchaffHVGayariMMIlstrupDMMeltonLJIII. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA. 1998;280(22):1926–1929.
31.
PannuHTran-FaduluVPapkeCL. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet. 2007;16(20):2453–2462.
32.
MannCJ.Observational research methods. Research design II: cohort, cross sectional, and case–control studies. Emerg Med J. 2003;20(1):54–60.
33.
ReevesBCDeeksJJHigginsJPWellsGA. Chapter 13: Including non-randomized studies. In: HigginsJPGreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011.http://www.cochrane-handbook.org. Accessed March 31, 2016, Updated March 2011.
34.
DeeksJJDinnesJD’AmicoR; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii–x, 1–173.
35.
Delgado-RodríguezMLlorcaJ. Bias. J Epidemiol Community Health. 2004;58(8):635–641.
